Butterfly Network (BFLY) Cash from Financing Activities (2020 - 2026)

Butterfly Network (BFLY) reported Cash from Financing Activities of $2.3 million for Q1 2026, down 97.06% on a YoY basis from $78.5 million in Q1 2025, and up 236.47% sequentially from -$1.7 million in Q4 2025.

Butterfly Network (BFLY) Cash from Financing Activities (2020 - 2026) Analysis & Trends

Butterfly Network (BFLY) has 7 years of Cash from Financing Activities data on file, last reported at $2.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Financing Activities fell 97.06% year-over-year to $2.3 million; the trailing twelve-month figure through Mar 2026 stood at $1.6 million (down 97.92% YoY), and the FY2025 full-year result was $77.8 million, up 5301.47% from the prior year.
  • Cash from Financing Activities improved to $2.3 million in Q1 2026, from -$1.7 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $78.5 million in Q1 2025 to a low of -$1.7 million in Q4 2025.
  • A 5-year average of $7.4 million and a median of $159000.0 in 2022 frame the typical range for Cash from Financing Activities.
  • Across the five-year window, Cash from Financing Activities slumped 99.9% in 2022 and fell 13.18% in 2025, its largest moves.
  • Tracing BFLY's Cash from Financing Activities over 5 years: stood at $137000.0 in 2022, then tumbled by 32.85% to $92000.0 in 2023, then tumbled by 1725.0% to -$1.5 million in 2024, then dropped by 13.18% to -$1.7 million in 2025, then surged by 236.47% to $2.3 million in 2026.
  • Business Quant data shows BFLY's Cash from Financing Activities at $2.3 million in Q1 2026, -$1.7 million in Q4 2025, and $987000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn 17.31 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -1.51 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -888.00 Mn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -451.20 Mn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -25.00 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 21.00 Mn
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn -26.93 Mn
10 Butterfly Network 1.79 Bn 1.65 Bn 18.29 Mn 2.31 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.31 Mn
Mar 31, 2026 2.31 Mn
Dec 31, 2025 -1.69 Mn
Dec 31, 2025 -1.69 Mn
Jun 30, 2025 987,000.00
Jun 30, 2025 987,000.00
Mar 31, 2025 78.47 Mn
Mar 31, 2025 78.47 Mn
Dec 31, 2024 -1.50 Mn
Dec 31, 2024 -1.50 Mn
Sep 30, 2023 92,000.00
Sep 30, 2023 92,000.00
Jun 30, 2023 136,000.00
Jun 30, 2023 136,000.00
Dec 31, 2022 137,000.00
Dec 31, 2022 137,000.00
Sep 30, 2022 2.04 Mn
Sep 30, 2022 2.04 Mn
Jun 30, 2022 159,000.00
Jun 30, 2022 159,000.00